Journal
PHARMACOLOGY RESEARCH & PERSPECTIVES
Volume 8, Issue 4, Pages -Publisher
JOHN WILEY & SONS LTD
DOI: 10.1002/prp2.623
Keywords
angiotensin-converting enzyme; COVID-19; inflammation; SARS-CoV-2; therapy
Categories
Ask authors/readers for more resources
Coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 novel coronavirus, has spread worldwide causing high fatality rates. Neither a vaccine nor specific therapeutic approaches are available, hindering the fight against this disease and making better understanding of its pathogenesis essential. Despite similarities between SARS-CoV-2 and SARS-CoV, the former has unique characteristics which represent a great challenge to physicians. The mechanism of COVID-19 infection and pathogenesis is still poorly understood. In the present review, we highlight possible pathways involved in the pathogenesis of COVID-19 and potential therapeutic targets, focusing on the role of the renin-angiotensin-aldosterone system.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available